GLP-1 BASED THERAPY OF OBESITY AND TYPE 2 DIABETES

Descargar Publicación
Efficacy and safety of orforglipron in adults with body mass index of 27 to less than 30 kg/m2 and adiposity-related complications: A post hoc analysis of the ATTAIN-1 trial Ultraprocesados: el etiquetado no revela toda la verdad